US Stock MarketDetailed Quotes

GTHX G1 Therapeutics

Watchlist
  • 4.675
  • -0.015-0.32%
Trading May 16 12:58 ET
244.42MMarket Cap-7791P/E (TTM)

About G1 Therapeutics Company

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.

Company Profile

SymbolGTHX
Company NameG1 Therapeutics
Listing DateMay 17, 2017
Issue Price15.00
Founded2008
CEOMr. John E. Bailey, Jr
MarketNASDAQ
Employees100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address700 Park Offices Drive,Suite 200
CityResearch Triangle Park
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27709
Phone1-919-213-9835
Websitehttp://www.g1therapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • John E. Bailey, Jr
  • Director, President and Chief Executive Officer
  • 3.25M
  • Monica R. Thomas
  • Chief Legal and People Officer
  • --
  • John W. Uead, V
  • Chief Financial Officer
  • --
  • Andrew Perry
  • Chief Commercial Officer
  • --
  • Mark Avagliano
  • Chief Business Officer
  • 1.17M
  • Terry L. Murdock
  • Chief Operating Officer
  • --
  • Dr. Rajesh K. Malik, M.D.
  • Chief Medical Officer
  • 1.11M
  • Garry A. Nicholson
  • Chairman of the Board
  • 195.35K
  • Alicia Secor
  • Independent Director
  • 142.85K
  • Cynthia L. Flowers
  • Independent Director
  • 162.85K
  • Jacks Lee
  • Independent Director
  • 145.35K
  • Glenn P. Muir
  • Independent Director
  • 172.85K
  • Dr. Norman E. Sharpless, M.D.
  • Independent Director
  • 135.35K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg